CR Rate of 30% With Agent for High-Risk Bladder Cancer CR Rate of 30% With Agent for High-Risk Bladder Cancer

With a complete response (CR) rate of 30%, the experimental agent CG0070 is in a race to be the first drug since 1998 for the treatment of BCG-unresponsive bladder cancer.Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news